<em id="o0zyl"></em>
    <sub id="o0zyl"></sub><wbr id="o0zyl"></wbr>
      <em id="o0zyl"><source id="o0zyl"><option id="o0zyl"></option></source></em>

      1. <em id="o0zyl"><span id="o0zyl"></span></em>

          Analyst Coverage

          To our knowledge the following list presents the analysts publishing material commenting on Abcam. We provide this list for your convenience only and do not endorse or express any opinion on the reports these analysts publish.

          Company Analyst
          Berenberg Charles Weston
          Investec Andrew Whitney
          JP Morgan Cazenove David Adlington
          Numis Securities Stefan Hamill
          Panmure Gordon & Co Julie Simmonds
          Peel Hunt Amy Walker
          RBC Securities Nick Keher
          Stifel James Mainwaring

          About Abcam

          Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

          Read more +

          Abcam Products

          As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

          Read more +

          Investor Information

          Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

          Read more +

          Abcam News

          We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

          Read more +
          好吊妞在线新免费视频